Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome
Dr. Tesha Monteith discusses the Neurology article, "Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome: Results From the Randomized PRODROME Trial" by…
Read the full articleYou might also wanna read
Study to Assess Effectiveness of Oral Atogepant in Adult Participants For Prevention of Migraine in the United Kingdom
Conditions : Migraine Sponsors : AbbVie Not yet recruiting
Intranasal Zavegepant for the acute treatment of migraine in adults: A review of randomized clinical trials
Migraine is a highly prevalent chronic neurological disorder and one of the leading causes of disability worldwide. Among recent therapeutic
Rimegepant Effective in Treatment-Resistant Migraine
Rimegepant is safe and effective in patients with migraine not responding to multiple prior preventive therapies, a real-world study shows.
Evolution of the Cognitive Profile and Quality of Life of Adult Patients Suffering From Severe Migraines Under Preventive Treatment
Conditions : Chronic Migraine Interventions : Behavioral: Cognitive assessment mapping Sponsors : University Hospital, Strasbourg, France No
CME | This Is Giving Me a Headache: Managing the Headache Patient Without Losing Your Mind
In this re-released episode of CME on the Go, originally published on 12/1/2025, our hosts discuss the complexities of diagnosing and treati
Study to Assess How Different Oral Formulations of Ubrogepant Move Through the Body in Healthy Adult Participants
Conditions : Healthy Volunteer Interventions : Drug: Ubrogepant; Drug: Ubrogepant Sponsors : AbbVie Not yet recruiting
Comments
Sign in to join the conversation.
No comments yet. Be the first.